Quick Answer
CRISPR Therapeutics AG reported Shares Outstanding of 95.89 million shares for fiscal year 2025.
CRISPR Therapeutics AG Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 95.89M | +11.8% |
| 2024 | 85.74M | +7.1% |
| 2023 | 80.04M | +2.0% |
| 2022 | 78.51M | +2.0% |
| 2021 | 76.99M | +4.2% |
| 2020 | 73.91M | +21.6% |
| 2019 | 60.78M | +17.2% |
| 2018 | 51.85M | +27.7% |
| 2017 | 40.59M | +2.2% |
| 2016 | 39.72M | +618.5% |
| 2015 | 5.53M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 93.87M | +10.0% | +6.2% |
| June 30, 2025 | 88.38M | +3.9% | +2.3% |
| March 31, 2025 | 86.36M | +1.8% | +0.7% |
| December 31, 2024 | 85.74M | +7.1% | +0.5% |
| September 30, 2024 | 85.34M | +7.4% | +0.3% |
| June 30, 2024 | 85.05M | +7.1% | +0.2% |
| March 31, 2024 | 84.84M | +7.6% | +6.0% |
| December 31, 2023 | 80.04M | +2.0% | +0.8% |
- CRISPR Therapeutics AG showed an increase of +11.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2015–2025 period, CRISPR Therapeutics AG’s shares outstanding has grown by 1634.7% (from 5.53 million shares to 95.89 million shares).
- The most recent figure is from CRISPR Therapeutics AG’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: